Adrenocortical, somatotropic and antidiuretic response to nasal glucagon in healthy subjects.
Emanuele VaraldoFabio BiolettoDaniela CuboniNunzia PrencipeChiara BonaMarco BaraleEzio GhigoSilvia GrottoliAlessandro Maria BertonValentina GascoPublished in: European journal of endocrinology (2023)
Intranasal glucagon administration is not an effective stimulus for hypophyseal secretion. Hypokalemia secondary to hyperinsulinemic rebound appears to be a frequent complication of its acute administration.